Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
Quick Stats
Jan 30, 202655.6
AI Score
HOLD1.33
Volume Ratio
Apr 14, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
NRIX Stock Summary
Last updated Jan 30, 2026
NRIX is currently trading at $16.52, positioned above its 200-day moving average of $12.63, indicating a long-term uptrend. The stock has a 52-week range of $8.18 to $22.4999.
Technical Analysis: The 50-day moving average stands at $18.23, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.802, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.096, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NRIX at 55.6/100 with a HOLD recommendation.
NRIX (Nurix Therapeutics, Inc. Common stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.802 |
| CMF (20) | -0.096 |
| ROC (10) | -12.407 |
| ADX (14) | 20.776 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.052 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -94.819 |
| MFI (14) | 45.684 |
NRIX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NRIX Price vs Max Options Open Interest
NRIX Max Change In Options Open Interest
NRIX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRIX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRIX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NRIX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Nurix Therapeutics, Inc. Common stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NRIX Moving Averages Analysis
Nurix Therapeutics, Inc. Common stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
NRIX (Nurix Therapeutics, Inc. Common stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 18.46 |
| 20 | 18.46 |
| 30 | 18.63 |
| 50 | 18.23 |
| 100 | 14.31 |
| 200 | 12.63 |
NRIX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.8 billion |
| Earnings/Share ($) | -2.97 |
| Net Proft Margin (%) | -2.925 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.0971 |
| EPS Estimate Next Year ($) | -3.457 |
| WallStreet Target Price ($) | 29.5882 |
| Most Recent Quarter |